(DANRE) adra2a Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP21215c
Background:
Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The order of potency for this receptor is dexmedetomidine > oxymetazoline = epinephrine > norepinephrine.
Other Names:
Alpha-2A adrenergic receptor, Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR, adra2a
Target/Specificity:
The synthetic peptide sequence is selected from aa 223-236 of HUMAN adra2a
Gene Name: adra2a {ECO:0000250|UniProtKB:P08913}
Primary Accession: Q90WY4
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The order of potency for this receptor is dexmedetomidine > oxymetazoline = epinephrine > norepinephrine.
Other Names:
Alpha-2A adrenergic receptor, Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR, adra2a
Target/Specificity:
The synthetic peptide sequence is selected from aa 223-236 of HUMAN adra2a
Gene Name: adra2a {ECO:0000250|UniProtKB:P08913}
Primary Accession: Q90WY4
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review